Why AI matters at this scale

Merck Animal Health, operating at a global enterprise scale with over 10,000 employees, is a leader in the development, manufacturing, and marketing of veterinary pharmaceuticals, vaccines, and health management solutions. The company serves both livestock producers and companion animal veterinarians, managing complex R&D pipelines, global supply chains, and direct customer relationships. At this magnitude, incremental efficiency gains translate into hundreds of millions in value, and strategic innovation is crucial for maintaining market leadership in a competitive sector.

For a corporation of this size in pharmaceuticals, AI is not a futuristic concept but a present-day imperative. The core business challenges—exorbitant R&D costs, lengthy development cycles, stringent regulatory hurdles, and personalized customer engagement—are all areas where AI delivers disproportionate returns. Large enterprises have the data assets, capital, and institutional partnerships necessary to deploy AI at scale, turning vast datasets into predictive insights and automated processes that smaller players cannot match.

Concrete AI Opportunities with ROI Framing

1. Accelerating R&D with Generative AI

The traditional drug discovery process for animal health can take over a decade and cost billions. By deploying generative AI models to simulate molecular interactions and predict compound efficacy for specific animal diseases, the company can identify promising candidates in months instead of years. The ROI is clear: reducing the early-stage pipeline by 20-30% could save hundreds of millions annually and accelerate time-to-market for critical vaccines, capturing market share faster.

2. Optimizing Global Manufacturing & Supply Chains

Producing biologicals like vaccines requires precise, capital-intensive manufacturing and temperature-controlled logistics. AI-powered digital twins can simulate production lines to optimize yield and prevent downtime. Furthermore, machine learning models that integrate weather, disease outbreak, and historical sales data can forecast regional demand with high accuracy. This minimizes waste from overproduction and prevents costly stockouts, directly protecting revenue and improving margins in a low-margin logistics environment.

3. Enhancing Direct Customer Engagement & Services

Beyond products, the future of animal health lies in data-driven services. By aggregating anonymized data from farms and clinics, AI can generate personalized insights for veterinarians and producers. For example, predictive algorithms could warn a dairy farmer of a heightened mastitis risk based on local weather and herd metrics, coupled with a tailored treatment protocol. This transforms the company from a product vendor to an essential health partner, driving customer retention and creating lucrative subscription-based service models.

Deployment Risks Specific to Large Enterprises

Implementing AI in a 10,000+ employee pharmaceutical giant comes with unique hurdles. Data Silos & Integration: Critical data is often trapped in legacy systems across research, regulatory, manufacturing, and commercial divisions. Breaking down these silos requires substantial investment in data engineering and governance, alongside cultural shifts to promote data sharing. Change Management & Skill Gaps: Scaling AI requires upskilling or hiring hundreds of data scientists and ML engineers, and convincing veteran researchers and sales teams to trust and adopt AI-driven recommendations. Regulatory Scrutiny: Any AI model used in drug discovery, manufacturing, or safety monitoring must be fully validated, documented, and explainable to satisfy global regulators like the FDA. The "black box" nature of some advanced AI poses a significant compliance risk that must be meticulously managed through rigorous MLOps and audit trails.